FIGURE
Fig. 3
- ID
- ZDB-FIG-210426-31
- Publication
- Cinzia et al., 2021 - Therapeutic efficacy of 3,4-Diaminopyridine phosphate on neuromuscular junction in Pompe disease
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 3
3,4-Diaminopyridine phosphate improved NMJs in zebrafish embryos. (A) Electron micrographs showing a swollen and convoluted end-plate in a morphant, a normal appearing end-plate in a 3,4-DAPP treated morphant and a normal endplate in a control embryo. Note the synaptic cleft (white arrows) and active zones (black arrows). Scale bar = 2 µm. (B,C) Quantification of the percentage of NMJs presenting normal structure (B), and of acetylcholine vesicles (C), in the three experimental groups. Error bars are SEMs. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
| Fish: | |
|---|---|
| Condition: | |
| Knockdown Reagent: | |
| Observed In: | |
| Stage: | Long-pec |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Biomed. Pharmacother.